Equites Radar

NUTX · Nutex Health Inc.

Medical Care FacilitiesUnited StatesAnalyst view: Strong Buy

$200.24

+2.58% last session

End-of-day data · close of 2026-09-11

Bullish4 bullish · 1 bearish technical signals
Consensus: Strong Buy (1.20 from 5 analysts)
To mean target: +45.0%

Market cap

$1B

Enterprise value

$2B

Trailing P/E

7.7

Forward P/E

9.6

Dividend yield

Beta

2.02

Avg volume

0M

Employees

1K

Daily Change %

2.58%

5 Days Change

2.30%

10 Days Change

4.73%

30 Days Change

18.76%

60 Days Change

7.49%

Month to Day Change

5.52%

Year to Day Change

20.08%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.20
Covering analysts5
Mean price target$283.00
Low price target$200.00
Upside to mean target+45.0%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)61.6
50-day MA$176.75
200-day MA$142.59
Price vs 50-day MA+13.3%
Price vs 200-day MA+40.4%
MACD histogram-0.18
Volume vs 3-month avg1.0×
52w low $87.0152w high $200.24

Analyst sentiment over time — NUTX

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-09-04

Latest call per bank · past 12 months

Recent rating actions

DateFirmActionRatingPrice target
2026-09-04B. Riley SecuritiesMaintainsBuy$290 $325
2026-08-11Lake StreetMaintainsBuy$235 $310
2026-06-26B. Riley SecuritiesInitiatesBuy$0.00 $290
2026-06-02Lake StreetInitiatesBuy$0.00 $235

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 62 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 13.3% above the 50-day MA ($176.75).
  • Price vs 200-day MA: Trading 40.4% above the 200-day MA ($142.59).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.18) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($200.24).

NUTX Price Chart

Loading chart for NUTX

Fundamentals

Revenue (TTM)$1.0B
EBITDA$1.0B
Free cash flow$0M
Operating cash flow$0M
Book value / share$57.62
Net Debt / EBITDA0.3
WACC18.0%
Revenue growth-14.00%
Earnings growth

About Nutex Health Inc.

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

More in Medical Care Facilities

Screen NUTX against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.